BSE filing, NSE: BI. Summary written from the filing by ALFA Finder's alert engine.
Bilcare Ltd: key numbers
- Share price
- ₹81.12
- Market cap
- ₹191.0 Cr
- Revenue (annual)
- ₹733.5 Cr
- Net profit (annual)
- ₹1.73 Cr
- P/E (TTM)
- 24.6×Sector 51.1×
- Promoter holding
- 30.01%+0.00% QoQ
- FII holding
- 0.04%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bilcare Ltd
All →Bilcare Board Meeting Date
Bilcare Limited scheduled a board meeting for 3 November 2026 to consider its unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The results have not yet been approved, so this is only a notice.
Bilcare Merger & Restructuring
Bilcare Limited announced the dissolution of its wholly-owned subsidiary, Bilcare INC US, effective September 9, 2026. This action holds no material financial impact.
Bilcare Annual General Meeting
Bilcare Limited issued a corrigendum for its 39th Annual General Meeting, correcting a clerical error where a director's appointment resolution was mislabeled as a special resolution.
Bilcare Capital Structure Change
Non-promoter Guttikonda Anuradha, Vara Lakshmi and Rajasekhar bought 4,73,264 Bilcare shares in the open market, lifting PAC holdings to 16.47%. No transaction price was disclosed.
Bilcare Management Change
Bilcare Limited has appointed Mr. Mohan Bhandari and re-appointed Ms. Kavita Bhansali as Executive Directors for a three-year term, effective August 2026.
Bilcare Annual General Meeting
Bilcare Limited issued the Notice for its 39th Annual General Meeting scheduled for September 26, 2026, to transact six agenda items, including related party transaction approvals.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.